CD4 and neoplasm: In addition, flowcytometry analysis of tumor infiltrating immune cells showed that mPRMT1 restored the increased immune suppressive CD11b+Gr1+MDSC and reduced CD8+ T cells of mRIP3 tumors, but not affecting the ratio of CD4+ T cells (Figs. 5E–H and S5A).